findmyKOL

Glenn Yiu, MD

Enriched profile

Director of Tele-Ophthalmology and Professor, Department of Ophthalmology, UC Davis Health · UC Davis Health System

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Sacramento, CA · West · United StatesSpecialtyRetina SpecialistFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceNone verifiedPayments2021–2025NIH funding2016–2026

Glenn Yiu is Director of Tele-Ophthalmology and Professor, Department of Ophthalmology, UC Davis Health at UC Davis Health System. OpenAlex indexes 237 publications with 6,649 citations (h-index 38); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Retina Specialist profiles in the findmyKOL directory.

Data verified 7 Oct 2026

Overview

Updated 12 Oct 2026

Glenn Yiu, MD, PHD, is Director of Tele-Ophthalmology and Professor, Department of Ophthalmology, UC Davis Health at UC Davis Health System (Department of Ophthalmology & Vision Science, Ernest E. Tschannen Eye Institute, Sacramento, CA). The public record shows 237 publications with 6,649 citations (h-index 38), centered on Retinal Diseases and Treatments, Retinal Imaging and Analysis, Retinal and Macular Surgery. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 17 companies, 4 NIH-funded awards (2016–2026).

  • Most recent indexed publication: 2025 · Journal of vitreoretinal diseases
  • Top research focus: Retinal Diseases and Treatments
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 17 companies

Generated from the cited public record · current as of 12 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Macular Degeneration (AMD)1 trialDiabetic Complications1 trialDiabetic Retinopathy / DME1 trialEdema1 trialMacular Edema1 trial

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Macular SurgeryOcular Diseases and Behçet’s SyndromeRetinal Development and Disorders

Drugs & molecules

across trials, industry payments and publications
Xiperegeneric · TriamcinoloneClinical trials—Industry payments23Publications1Susvimogeneric · RanibizumabClinical trials—Industry payments11Publications1Vabysmogeneric · FaricimabClinical trials—Industry payments5Publications1Eyleageneric · AfliberceptClinical trials—Industry payments1Publications2Izervaygeneric · Avacincaptad pegolClinical trials—Industry payments2Publications—Syfovregeneric · PegcetacoplanClinical trials—Industry payments2Publications—Loteprednol etabonateClinical trials—Industry payments1Publications—Ozurdexgeneric · DexamethasoneClinical trials—Industry payments1Publications—Prolensageneric · BromfenacClinical trials—Industry payments1Publications—Sodium ascorbateClinical trials—Industry payments1Publications—Vyzultageneric · Latanoprostene bunodClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments33Bausch & Lomb Americas Inc.Clinical trials—Industry payments24Genentech USA, Inc.Clinical trials—Industry payments15Merck Sharp & Dohme LLCClinical trials—Industry payments13Alcon Vision LLCClinical trials—Industry payments4Alcon Research LLCClinical trials—Industry payments3Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments3Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments2Iridex CorporationClinical trials—Industry payments2Samsung Bioepis Co., Ltd.Clinical trials—Industry payments2University of California, DavisClinical trials2Industry payments—Astellas Pharma Global DevelopmentClinical trials—Industry payments1Astellas Pharma US IncClinical trials—Industry payments1Cardinal Health 110 LLCClinical trials—Industry payments1Genentech, Inc.Clinical trials—Industry payments1Janssen Research & Development, LLCClinical trials—Industry payments1Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
237publications

Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.

6,649citations

Total citations across indexed works.

38h-index

Hirsch index (OpenAlex). i10-index 84.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
17companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
4NIH grants · 2016–2026

Federally funded research awards.

View funding ↓

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 12 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 12 Oct 2026

17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 27 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 12 Oct 2026

4 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:

All 13 award records: search, sort and filter.Explore →

Congress activity

Updated 12 Oct 2026

1 congress contribution (2024) across ADA per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 12 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 18 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Glial inhibition of CNS axon regeneration
    Review1,518 citations2006
    doi.org ↗
  2. 02
    A TNF Receptor Family Member, TROY, Is a Coreceptor with Nogo Receptor in Mediating the Inhibitory Activity of Myelin Inhibitors
    Article392 citations2005
    doi.org ↗
  3. 03
    EGFR Activation Mediates Inhibition of Axon Regeneration by Myelin and Chondroitin Sulfate Proteoglycans
    Article366 citations2005
    doi.org ↗
  4. 04
    A third member of the synapsin gene family
    Article247 citations1998
    doi.org ↗
  5. 05
    TENAYA and LUCERNE
    Article227 citations2024
    doi.org ↗
All 237 cited works: search, sort and filter.Explore →

Network

Updated 12 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Ala Moshiri46Sara M. Thomasy38Sina Farsiu26Parisa Emami-Naeini19Charles C. Wykoff19Sook Hyun Chung18Susanna S. Park17David Cunefare16Rahul N. Khurana16Soo-Hyun Kim15Maurízio Battaglia Parodi14Lawrence S. Morse14Jay Kumar Chhablani14Panisa Singhanetr13Marion Ronit Munk13Halit Winter13Sangwan Park13Niroj Kumar Sahoo13Zachary A. Kroeger13Yusuf Ashfaq13Jeffrey A. Roberts12Stela Vujosevic12Tzu-Ni Sin11Lihteh Wu11Elad Moisseiev11Marco Lupidi11Lorenzo Pili11Lisa Checchin11Priya Shah11Samer Khateb10Arman Zarnegar10Iris Natalie Mollhoff10Eric Tieu10Yin Liu10Bita Momenaei10Lorenzo Ferro Desideri10Kieu-Yen Luu10Nasiq Hasan10Carol Villafuerte-Trisolini10Felicia Hertkorn10

Online presence

Updated 12 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    health.ucdavis.edu/news/headlines/uc-davis-health-ophthalmologist-glenn-yiu-honored-for-retina-research/2024/05

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu ↗
  • Other

    asrs.org/find-a-specialist/profile/9223

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 12 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    Harvard Medical School

    2008
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu ↗
  • Ph.D.

    Neuroscience, Harvard Medical School

    2006
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu ↗
  • B.A.

    Columbia University

    2000
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu ↗
  • Board-certified vitreoretinal specialist
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu ↗

Editorial & leadership roles

journal and society appointments
  • Scientific Advisory Board member

    Clearside Biomedical

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globenewswire.com ↗
  • Elected member

    Retina Society

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ois.net ↗
  • Elected member

    Macula Society

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ois.net ↗
  • Member

    American Society of Retina Specialists

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
  • Editorial board member

    Scientific Reports

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myrotx.com ↗
  • Editorial board member

    Frontiers in Genome Editing

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myrotx.com ↗
  • Member

    ARVO Annual Meeting Program Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myrotx.com ↗
  • Course lecturer

    American Academy of Ophthalmology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myrotx.com ↗
  • Editor

    textbook "Vitreoretinal Disorders"

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Clinical Advisor

    Neuro-ophthalmology, Myrobalan Therapeutics

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myrotx.com ↗
  • Consultant for multiple pharmaceutical/device companies

    including 4DMT, AbbVie, Adverum Biotechnologies, Alcon, Bausch + Lomb, Boehringer Ingelheim, Endogena Therapeutics, Genentech, Iridex, Janssen Pharmaceuticals …

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ophthalmologytimes.com ↗
  • Director

    UC Davis Reading Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.ucdavis.edu ↗

Media & interviews

press, podcasts and appearances
  • Distinguished Speaker Series lecture

    "Gene Therapy & Genome Editing for Age-Related Macular Degeneration," UC Irvine Center for Translational Vision Research

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ctvr.uci.edu ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.